血管钙化相关microRNA研究进展
DOI:
作者:
作者单位:

(中南大学湘雅二医院心血管外科,湖南省长沙市 410000)

作者简介:

唐勤伟,硕士研究生,研究方向为心脏瓣膜病,E-mail:13973588689@163.com。通信作者刘立明,博士,主任医师,博士研究生导师,研究方向为心脏瓣膜病和心房颤动,E-mail:liulimingjia@csu.edu.cn。

通讯作者:

基金项目:

湖南省科技创新计划项目(2021JC0003)


Research progress of microRNA related to vascular calcification
Author:
Affiliation:

Department of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    血管钙化是多种疾病的病理基础,主要机制是钙磷的异常沉积。微小核糖核酸(miRNA)是一类短小的非编码RNA分子,参与基因的转录与翻译过程。研究发现,在高磷、高糖环境或慢性肾脏病的病理条件下,miRNA的表达会出现变化。这些变化通过不同的信号通路,影响血管平滑肌细胞的成骨化转变以及成骨标志物的表达,进而促进或抑制血管钙化的进程。miRNA有望成为治疗血管钙化的靶点或者反映血管钙化水平的标志物。本文旨在总结miRNA调控血管钙化的机制通路和相关成果,为miRNA和血管钙化研究提供参考。

    Abstract:

    Vascular calcification is the pathological basis of multiple diseases, and its main mechanism is the abnormal deposition of calcium and phosphorus. MicroRNAs (miRNA) are a class of short non-coding RNA molecules that participate in the processes of gene transcription and translation. Studies have shown that miRNA expression is altered under pathological conditions such as hyperphosphatemia, hyperglycemia, or chronic kidney disease. These alterations, via different signaling pathways, affect the osteogenic transdifferentiation of vascular smooth muscle cells and the expression of osteogenic markers, and thus promote or inhibit the progression of vascular calcification. miRNA hold promise as therapeutic targets for vascular calcification or biomarkers reflecting the level of vascular calcification. This paper aims to summarize the mechanism pathways and relevant achievements of miRNA in regulating vascular calcification, providing a reference for the research on miRNA and vascular calcification.

    参考文献
    相似文献
    引证文献
引用本文

唐勤伟,谭昊宇,刘立明.血管钙化相关microRNA研究进展[J].中国动脉硬化杂志,2026,34(1):80~86.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2024-12-11
  • 最后修改日期:2025-03-06
  • 录用日期:
  • 在线发布日期: 2026-01-30